Clinical Trial Update: Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease [NA]

View source ↗

Summary

This clinical trial update assesses the efficacy and safety of discontinuing 5-ASA therapy in patients with inflammatory bowel disease, including ulcerative col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Ulcerative Colitis (UC), Crohn's Disease | NA | Status: NOT_YET_RECRUITING